Castle Biosciences (CSTL) Q2 2025 Earnings

5MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.9
-0.49
-0.09
0.32

Details

Expected EPS
-0.069447
Actual EPS
-0.9
Surprise EPS
-0.83
Surprise Percent
+1,195.95%

Description

Castle Biosciences (CSTL) has reported earnings of -0.9 per share for Q2 2025.

0 Comments

Share your thoughts